References
- GoedertMSpillantiniMGA century of Alzheimer’s diseaseScience20133145800777781
- BrambillaDLe DroumaguetBNicolasJNanotechnologies for Alzheimer’s disease: diagnosis, therapy, and safety issuesNanomedicine20117552154021477665
- BassoMYangJWarrenLVolumetry of amygdala and hippocampus and memory performance in Alzheimer’s diseasePsychiatry Res2006146325126116524704
- AnekondaTSReddyPHCan herbs provide a new generation of drugs for treating Alzheimer’s disease?Brain Res Rev200550236137616263176
- HampelHFrankRBroichKBiomarkers for Alzheimer’s disease: academic, industry and regulatory perspectivesNat Rev Drug Discov20109756057420592748
- Garcia-AyllonMSSilveyraMXSaez-ValeroJAssociation between acetylcholinesterase and beta-amyloid peptide in Alzheimer’s cerebrospinal fluidChem Biol Interact20081751–320921518554581
- AndersonNGMallerJLTonksNKSturgillTWRequirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinaseNature199034362596516532154696
- JohnsonGLLapadatRMitogen-activated protein kinase pathway mediated by ERK, JNK, and p38 protein kinaseScience200229856001911191212471242
- WidmannCGibsonSJarpeMBJohnsonGLMitogen-activated protein kinase: conservation of a three-kinase module from yeast to humanPhysiol Rev19997911431809922370
- SchnyderAHuwylerJDrug transport to brain with targeted liposomesNeurotherapeutics20052199107
- OnoKHasegawaHNaikiHYamadaMCurcumin has potent antiamyloidogenic effects for Alzheimer’s beta-amyloid fibrils in vitroJ Neurosci Res200475674275014994335
- ManogaranERamanathanMMohamedAAIdentification of curcumin targets in neuroinflammatory pathways: molecular docking scores with GSK-3β, p38 MAPK, COX, ICE and TACE enzymesActa Pol Pharm2012662237245
- LeeWHLooCYBebawyMLukFMasonRSRohanizadehRCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryCurr Neuropharmacol201311433837824381528
- PriyadarsiniKIThe chemistry of curcumin: from extraction to therapeutic agentMolecules20141912200912011225470276
- BottgerDUllrichCHumpelCMonocytes deliver bioactive nerve growth factor through a brain capillary endothelial cell-monolayer in vitro and counteract degeneration of cholinergic neuronsBrain Res2010131210811920004179
- KuoYCChungCYTATVHL peptide-grafted alginate/poly(γ-glutamic acid) scaffolds with inverted colloidal crystal topology for neuronal differentiation of iPS cellsBiomaterials201233358955896622998813
- Sakiyama-ElbertSEHubbellJAControlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrixJ Control Release200069114915811018553
- GobbiMReFCanoviMLipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptideBiomaterials201031256519652920553982
- CamilleriAZarbCCaruanaMMitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenolsBiochim Biophys Acta20131828112532254323817009
- WeiXChenXYingMLuWBrain tumor-targeted drug delivery strategiesActa Pharm Sin B20144319320126579383
- GaoXWuBZhangQBrain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administrationJ Control Release2007121315616717628165
- KuoYCLuCHEffect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood–brain barrierColloids Surf B2011861225231
- KuoYCLiangCTInhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface antiepithelial growth factor receptorBiomaterials201132123340335021296415
- ShiXLuXZhanLRat hippocampal proteomic alterations following intrahippocampal injection of amyloid beta peptide (1–40)Neurosci Lett20115002879121699958
- PaxinosGWatsonCThe Rat Brain in Stereotaxic Coordinates7th edAmsterdam, the NetherlandsElsevier2013
- Lopez-PintoJMGonzalez-RodriguezMLRabascoAMEffect of cholesterol and ethanol on dermal delivery from DPPC liposomesInt J Pharm2005298111215896932
- MicheleLDZacconeAEiserEAnalytical theory of polymer-network-mediated interaction between colloidal particlesProc Natl Acad Sci U S A201210926101871019222679289
- WohlfartSGelperinaSKreuterJTransport of drugs across the blood–brain barrier by nanoparticlesJ Control Release2012161226427321872624
- HeftiFIs Alzheimer disease caused by lack of nerve growth factor?Ann Neurol19831311091106830157
- KuoYCLinCCRescuing apoptotic neurons from Alzheimer’s disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated neuron growth factor and curcuminInt J Nanomed20151026532672
- SongCPeridesGWangDLiuYFβ-Amyloid peptide induces formation of actin stress fibers through p38 mitogen-activated protein kinaseJ Neurochem200283482883612421354
- MorishimaYGotohYZiegJβ-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligandJ Neurochem2001211975517560
- MaQLZuoXYangFCurcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic miceJ Biol Chem201328864056406523264626
- BulbarelliALonatiECazzanigaETrkA pathway activation induced by amyloid-beta (Abeta)Mol Cell Neurosci200940336537319162192
- ObaraYYamauchiATakeharaSERK5 activity is required for nerve growth factor-induced neurite outgrowth and stabilization of tyrosine hydroxylase in PC12 cellsJ Biol Chem2009284356473
- Willaime-MorawekSBrami-CherrierKMarianiJCabocheJBruggBC-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosisNeuroscience2003119238739712770554
- KuoYCWangCTProtection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrinBiomaterials201435225954596424746790
- OddoSCaccamoATranLTemporal profile of amyloid-β (Aβ) oligomerization in an in vivo model of Alzheimer disease – a link between Aβ and tau pathologyJ Biol Chem200628131599160416282321
- DeMattosRBLuJTangYA plaque-specific antibody clears existing β-amyloid plaques in Alzheimer’s disease miceNeuron201276590892023217740
- TsaiYMChienCFTsaiTHCurcumin and its nano-formulation: the kinetics of tissue distribution and blood–brain barrier penetrationInt J Pharm2011416133133821729743
- DuJLuWLYingXDual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animalsMol Pharm20096390591719344115
- NakajimaWIshidaALangeMSApoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn ratJ Neurosci200020217994800411050120
- MeloJBAgostinhoPOliveiraCRInvolvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptideNeurosci Res200345111712712507730
- AhmedTGilanuAHInhibitory effect of curcuminoids on acetylcholin-esterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer’s diseasePharmacol Biochem Behav200991455455918930076
- Negre-SalvayreACoatrieuxCIngueneauCSalvayreRAdvanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitorsBr J Pharmacol2008153162017643134
- LovellMEhmannWButlerSMarkesberyWElevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer’s diseaseNeurology1995458159416017644059
- PraticoDUryuKLeightSTrojanoswkiJQLeeVMYIncreased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosisNeuroscience200121124183418711404403